行政数据在评估妊娠结局中的前景与陷阱 - Suppr

Suppr

超能文献

Promise and pitfalls of administrative data in evaluating pregnancy outcomes.

作者信息

Andrews Elizabeth B, Tennis Patricia

机构信息

RTI Health Solutions, 3040 Cornwallis Road, Research Triangle Park, NC 27709, USA.

出版信息

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1181-3. doi: 10.1002/pds.1499.

DOI:10.1002/pds.1499

PMID:17966108

Abstract

摘要

相似文献

Promise and pitfalls of administrative data in evaluating pregnancy outcomes.

Pharmacoepidemiol Drug Saf. 2007 Nov;16(11):1181-3. doi: 10.1002/pds.1499.

Pregnancy exposure registries: academic opportunities and industry responsibility.

Birth Defects Res A Clin Mol Teratol. 2009 Jan;85(1):93-101. doi: 10.1002/bdra.20525.

[New antidepressants in pregnancy and the risk of congenital malformations].

Arch Argent Pediatr. 2010 Apr;108(2):101-3. doi: 10.1590/S0325-00752010000200002.

Privacy issues in pharmacoepidemiology: the importance of weighing costs and benefits.

Pharmacoepidemiol Drug Saf. 2001 Dec;10(7):659-62. doi: 10.1002/pds.645.

Collection and analysis of drug safety data in pregnancy.

Can J Clin Pharmacol. 2007 Winter;14(1):e34-6. Epub 2007 Jan 5.

[Safety of antidepressive agents in pregnancy].

Med Clin (Barc). 2000 Mar 11;114(9):354-5. doi: 10.1016/s0025-7753(00)71290-5.

Risk of congenital malformations among infants exposed to antidepressants during pregnancy.

Pharmacoepidemiol Drug Saf. 2008 Apr;17(4):423. doi: 10.1002/pds.1577.

Determination of pregnancy outcome risk rates after exposure to an intervention.

Clin Pharmacol Ther. 2001 Jan;69(1):7-13. doi: 10.1067/mcp.2001.112364.

How do we best detect toxic effects of drugs taken during pregnancy? A EuroMap paper.

Drug Saf. 2002;25(1):21-32. doi: 10.2165/00002018-200225010-00003.

Using secondary data sources for pharmacoepidemiology and outcomes research.

Pharmacotherapy. 2009 Feb;29(2):138-53. doi: 10.1592/phco.29.2.138.

引用本文的文献

Selective serotonin reuptake inhibitor use patterns among commercially insured US pregnancies (2005-2014).

Arch Womens Ment Health. 2021 Feb;24(1):155-164. doi: 10.1007/s00737-020-01027-x. Epub 2020 Mar 28.

Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs.

Neurology. 2019 Jul 9;93(2):e167-e180. doi: 10.1212/WNL.0000000000007696. Epub 2019 Jun 12.

Use of existing electronic health care databases to evaluate medication safety in pregnancy: Triptan exposure in pregnancy as a case study.

Pharmacoepidemiol Drug Saf. 2018 Dec;27(12):1309-1315. doi: 10.1002/pds.4658. Epub 2018 Sep 21.

The impact of exposure to antidepressant medications during pregnancy on neonatal outcomes: a review of retrospective database cohort studies.

Eur J Clin Pharmacol. 2017 Sep;73(9):1055-1069. doi: 10.1007/s00228-017-2269-4. Epub 2017 Jun 9.

[Psychopharmacotherapy during pregnancy : Which antipsychotics, tranquilizers and hypnotics are suitable?].

Nervenarzt. 2016 Sep;87(9):943-54. doi: 10.1007/s00115-016-0192-z.

Probabilistic record linkage for monitoring the safety of artemisinin-based combination therapy in the first trimester of pregnancy in Senegal.

Drug Saf. 2013 Jul;36(7):505-13. doi: 10.1007/s40264-013-0059-1.

Algorithms to estimate the beginning of pregnancy in administrative databases.

Pharmacoepidemiol Drug Saf. 2013 Jan;22(1):16-24. doi: 10.1002/pds.3284. Epub 2012 May 2.

Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Eur J Clin Pharmacol. 2012 May;68(5):459-67. doi: 10.1007/s00228-011-1154-9. Epub 2011 Nov 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验